JAKs, Stats, and CK2?

Activating mutations in JAK2, a tyrosine kinase that serves as a critical signaling protein for multiple cytokines, are associated with BCR-ABL1 –negative myeloproliferative neoplasms. In this issue of Blood , Zheng and colleagues report that the constitutively activated kinase CK2 binds to JAK2

[1]  S. Meloche,et al.  Rho Family GTPases Are Required for Activation of Jak/STAT Signaling by G Protein-Coupled Receptors , 2003, Molecular and Cellular Biology.

[2]  J. O’Shea,et al.  Janus kinases in immune cell signaling , 2009, Immunological reviews.

[3]  R. Skoda,et al.  Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics , 2009, Nature Reviews Clinical Oncology.

[4]  D. Litchfield.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. , 2003, The Biochemical journal.

[5]  A. Tefferi,et al.  A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. , 2011, Blood.

[6]  L. Pinna,et al.  One‐thousand‐and‐one substrates of protein kinase CK2? , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.